A new report from the Association of the British Pharmaceutical Industry has determined that the United Kingdom leads Europe in early clinical phases but falls short when it comes to later stage studies.
The advent of NGS analysis software has unraveled immense potential for directing and carrying out basic biological research by offering unparalleled prospects for accurate prognostics, diagnostics, and therapeutics in various domains of healthcare. The NGS analysis software aids the scientists in analyzing complex biological interpretations within the comfort of their homes instead of carrying out exhaustive, prolonged, clinical trials for the genetically stratified clinical trials. The developments of NGS analysis software and tools have undoubtedly facilitated the analysts in executing…
